Tag Archives: lung

UPDATE 3-US FDA approves Glaxo/Theravance drug for COPD lung disease

Posted on May 12, 2013 by admin

* Drug will compete with AstraZeneca’s Symbicort (Updates with FDA comment, side effects)

Posted in News | Tagged approves, COPD, disease, drug, Glaxo/Theravance, lung, update | Leave a comment

UPDATE 4-US FDA advisory panel backs Glaxo/Theravance lung drug

Posted on April 17, 2013 by admin

* Panel votes Breo effective in treating airflow obstruction

Posted in News | Tagged advisory, backs, drug, Glaxo/Theravance, lung, panel, update | Leave a comment

FDA advisory panel backs Glaxo/Theravance lung drug

Posted on April 17, 2013 by admin

(Reuters) – An advisory panel to the U.S. Food and Drug Administration has recommended that the agency approve an experimental treatment for smoking-related lung damage made by Britain’s GlaxoSmithKline Plc and Theravance Inc.

Posted in Business | Tagged advisory, backs, drug, Glaxo/Theravance, lung, panel | Leave a comment

Oncolytics lung cancer drug effective in mid-stage trial, shares up

Posted on March 31, 2013 by admin

(Reuters) – Oncolytics Biotech Inc said its experimental lung cancer drug was found to be more effective in a mid-stage trial study, sending its shares up more than 10 percent.

Posted in News | Tagged cancer, drug, effective, lung, midstage, Oncolytics, shares, trial | Leave a comment

Segregation tied to more lung cancer deaths: study

Posted on January 18, 2013 by admin

NEW YORK (Reuters Health) – Black lung cancer patients seem more likely to die of the disease than white cancer patients in the U.S., especially those living in segregated counties, according to a new study.

Posted in Business | Tagged cancer, deaths, lung, more, segregation, study, tied | Leave a comment

Ariad lung cancer drug shrinks tumors in small trial

Posted on September 30, 2012 by admin

(Reuters) – A small early-stage trial of Ariad Pharmaceuticals Inc’s experimental pill AP26113 showed it shrank tumors in eight out of 11 lung cancer patients with a genetic mutation in a gene known as ALK.